This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024Hynes Convention Center in Boston, USA

Mary Beth Pelletier, PhD
Associate Director, QC Analytical Technology at Biogen
Speaker

Profile

Dr. Mary Beth Pelletier is currently the Associate Director of QC Analytical Technology at Biogen in Research Triangle Park, NC, where her team supports development, optimization, validation, transfer, troubleshooting, and lifecycle maintenance of analytical methods for Biogen’s biologics portfolio from Phase 3 throughout the commercial lifecycle. She received her bachelor’s degree in chemistry from Northwestern University in Evanston, IL and her Ph.D. in chemistry from The Scripps Research Institute in La Jolla, CA. Prior to her positions at Biogen, Mary Beth worked in biologics formulation development and analytical development at Amgen in Thousand Oaks, CA and Talecris Biotherapeutics in Raleigh, NC.

Agenda Sessions

  • Next Generation Therapies have Next Generation Analytical Challenges

    2:00pm
  • Next Generation Therapies have Next Generation Analytical Challenges

    2:00pm